Question 1
Name an adverse effect and monitoring need specific to denosumab therapy.
Correct Answer:
Hypocalcemia risk; monitor serum calcium after initiation and ensure adequate calcium and vitamin D intake; assess for signs of infection and jaw osteonecrosis
Explanation:
Denosumab works by blocking RANKL, which reduces osteoclast activity and bone resorption. Because calcium is no longer being released from bone as readily, there is a real risk of hypocalcemia after starting therapy. This risk is why monitoring focuses on serum calcium soon after initiation—typically within the first week to a couple of weeks—and on ensuring adequate calcium and vitamin D intake to support normal calcium levels. Patients should be educated to recognize symptoms of low calcium such as tingling, muscle cramps, or numbness, and clinicians may adjust supplements as needed. Another important, therapy-specific concern is osteonecrosis of the jaw. Denosumab can increase this risk, especially around dental procedures or in the presence of dental infection, so a dental evaluation before starting treatment and ongoing monitoring for jaw pain, swelling, or non-healing dental wounds are advised. Together, these monitoring needs—watching calcium levels and protecting oral health—address the most characteristic adverse effects of denosumab and guide safe use.
Question 2
During teriparatide therapy, which lab values should be monitored?
Correct Answer:
Calcium, alkaline phosphatase, and uric acid
Explanation:
Teriparatide is an anabolic therapy that stimulates osteoblasts to form bone, so labs you monitor should reflect both calcium balance and bone turnover. Serum calcium is watched because this drug can raise calcium levels, and hypercalcemia can occur and needs attention. Alkaline phosphatase, particularly the bone-specific form, rises with osteoblastic activity and serves as a marker of bone formation—tracking it helps gauge how strongly the therapy is activating bone formation. Uric acid is monitored because increased bone turnover can elevate purine metabolism, potentially raising uric acid and increasing the risk of hyperuricemia or gout in some patients. These three labs together give a practical view of response and safety during teriparatide therapy; the other electrolytes listed don’t directly reflect the bone-forming action or the main risks of this treatment.
Question 3
Which factor is most associated with an increased risk of fat embolism syndrome after fracture?
Correct Answer:
Multiple long bone fractures
Explanation:
Fat embolism syndrome happens when fat from bone marrow enters the bloodstream after a fracture, especially from long bones. The lungs are the first place these droplets travel to, so respiratory symptoms and hypoxemia are common, and neuro or skin findings can follow within the first couple of days. When multiple long bones are fractured, a much larger amount of marrow fat is released, increasing the embolic load and the likelihood that fat droplets lodge in the pulmonary circulation or travel to other organs. That higher embolic burden explains why multiple long bone fractures are the strongest risk factor among the options. Prophylactic antibiotics don’t influence fat embolism risk, and an upper-extremity fracture typically involves less marrow fat than a long-bone or pelvic fracture, while advanced age is a broader risk factor but not as specifically predictive of fat embolism as the extent of skeletal injury.
Question 4
What action should the charge nurse take after overhearing a nurse disparaging a healthcare provider in the break room?
Correct Answer:
Meet privately with the nurse at once to discuss the conversation that was overheard.
Explanation:
Immediate, private management of unprofessional behavior is essential. When a nurse disparages a provider, it signals disrespect and can erode teamwork and patient safety if left unchecked. The best action is to address the issue face-to-face in private right away, giving concise feedback about how the remarks violate professional standards and outlining expectations for respectful communication going forward. This approach stops the behavior from normalizing, preserves the nurse’s dignity, and creates a learning moment rather than a public confrontation. It also provides a documented basis for follow-up if needed and aligns with workplace policies on conduct. Leaving the area to vent, encouraging discussion with a family member, or confronting the nurse publicly in the break room are less appropriate because they either fail to address the behavior directly, misdirect the issue, or escalate tension and undermine professionalism.
Question 5
What is the recommended total daily calcium intake and the upper limits?
Correct Answer:
Only dietary calcium; supplements not needed.
Explanation:
Total daily calcium intake is the sum of what you get from food and what you might take in supplements. For most adults, the goal is about 1000–1200 mg of elemental calcium each day. There’s a safety ceiling—the upper intake level—meant to prevent adverse effects like kidney stones or elevated calcium in the blood; this ceiling is typically around 2500 mg per day for younger adults and slightly lower for older adults, depending on the guideline. The key idea is to reach the recommended total from all sources without regularly exceeding the upper limit. If your diet already provides enough calcium to meet that 1000–1200 mg target, you wouldn’t necessarily need supplements. In that scenario, saying that calcium should come from dietary sources and that supplements aren’t required makes sense. However, many people don’t get enough calcium from food alone and would benefit from supplements to reach the target. So, the statement about relying on dietary calcium without needing supplements is correct in cases where dietary intake suffices, but not universally true for everyone.
Question 1
Exam overview

About this Exam

Prepare with the HESI Osteoporosis Case Study Practice Test practice quiz. This question bank includes 10 questions covering therapy, embolism, denosumab, monitored, and syndrome. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

HESI Osteoporosis Case Study Practice Test

This practice set contains 10 questions from the matching question bank and focuses on therapy, embolism, denosumab, monitored, and syndrome. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions